(Q47704888)
Statements
1 reference
Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer (English)
1 reference
Hiroshi Soeda
1 reference
Hideki Shimodaira
1 reference
Mika Watanabe
1 reference
Takao Suzuki
1 reference
Makio Gamoh
1 reference
Takahiro Mori
1 reference
Keigo Komine
1 reference
Noriyuki Iwama
1 reference
Shunsuke Kato
1 reference
Chikashi Ishioka
1 reference
26 May 2012
1 reference
18
1 reference
4
1 reference
670-677
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference